F. Shu

Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.

Yu Qin, M. Mi, Qian-yong Zhang, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Dihydromyricetin improves glucose and lipid metabolism and exerts anti-inflammatory effects in nonalcoholic fatty liver disease: A randomized controlled trial.

P. Liu, M. Mi, Jun-dong Zhu, 2015, Pharmacological research.

Daidzein supplementation decreases serum triglyceride and uric acid concentrations in hypercholesterolemic adults with the effect on triglycerides being greater in those with the GA compared with the GG genotype of ESR-β RsaI.

M. Mi, Jun-dong Zhu, Li Wang, 2014, The Journal of nutrition.

Ampelopsin Induces Cell Growth Inhibition and Apoptosis in Breast Cancer Cells through ROS Generation and Endoplasmic Reticulum Stress Pathway

M. Mi, Jun-dong Zhu, Yong Zhou, 2014, PloS one.

Fish Oil Supplements Lower Serum Lipids and Glucose in Correlation with a Reduction in Plasma Fibroblast Growth Factor 21 and Prostaglandin E2 in Nonalcoholic Fatty Liver Disease Associated with Hyperlipidemia: A Randomized Clinical Trial

Yong Zhou, Qian-yong Zhang, Xiao-lan Zhao, 2015, PloS one.

Ampelopsin-induced autophagy protects breast cancer cells from apoptosis through Akt-mTOR pathway via endoplasmic reticulum stress

M. Mi, Jun-dong Zhu, Yong Zhou, 2014, Cancer science.

Equol promotes rat osteoblast proliferation and differentiation through activating estrogen receptor.

B. Wang, J. Xu, F. Shu, 2014, Genetics and molecular research : GMR.